| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
51,277 |
41,706 |
$1.83M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,775 |
3,733 |
$281K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,332 |
3,288 |
$276K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,485 |
3,450 |
$274K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,756 |
6,019 |
$267K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,088 |
6,796 |
$203K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,548 |
2,517 |
$186K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,144 |
2,925 |
$157K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,558 |
2,650 |
$53K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,012 |
2,876 |
$40K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
452 |
446 |
$38K |
| 99000 |
|
2,861 |
2,725 |
$30K |
| 99381 |
|
348 |
347 |
$28K |
| 80053 |
Comprehensive metabolic panel |
2,812 |
2,630 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,929 |
2,734 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,057 |
1,525 |
$16K |
| 87807 |
|
1,157 |
1,005 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
201 |
199 |
$12K |
| 90461 |
|
1,040 |
808 |
$11K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
6,829 |
6,753 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
454 |
436 |
$6K |
| 96161 |
|
2,181 |
2,163 |
$5K |
| 92587 |
|
240 |
237 |
$4K |
| 81003 |
|
1,515 |
1,433 |
$3K |
| 86308 |
|
552 |
545 |
$2K |
| 94010 |
|
82 |
75 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
57 |
56 |
$2K |
| 90474 |
|
132 |
132 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
42 |
40 |
$981.60 |
| 97170 |
|
58 |
58 |
$550.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
28 |
27 |
$386.37 |
| 86580 |
|
30 |
30 |
$219.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$142.80 |
| 94760 |
|
78 |
76 |
$141.36 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
6,814 |
6,740 |
$30.00 |
| 90686 |
|
703 |
700 |
$18.96 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
28 |
27 |
$1.20 |
| 90716 |
|
28 |
28 |
$0.00 |
| 90696 |
|
41 |
41 |
$0.00 |
| 90651 |
|
29 |
28 |
$0.00 |
| 90680 |
|
209 |
209 |
$0.00 |
| 90723 |
|
355 |
354 |
$0.00 |
| 90648 |
|
573 |
573 |
$0.00 |
| 90633 |
|
144 |
143 |
$0.00 |
| 90734 |
|
207 |
204 |
$0.00 |
| 90715 |
|
60 |
59 |
$0.00 |
| 90670 |
|
640 |
638 |
$0.00 |
| 90710 |
|
104 |
104 |
$0.00 |
| 90658 |
|
15 |
15 |
$0.00 |
| 90707 |
|
19 |
19 |
$0.00 |